Swisscanto Private Equity

ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, develops advanced four-legged robots designed for various industrial applications. These autonomous mobile robots are engineered to enhance safety and productivity by navigating complex environments and performing routine inspections. Equipped with a suite of advanced sensors including visual zoom cameras, lidar scanners, and thermal cameras, ANYbotics' robots can monitor assets, detect gas presence, and create 3D models. Their robust design allows for operation in challenging terrains, making them suitable for sectors such as power, chemicals, construction, mining, and oil and gas. By automating inspection tasks and providing real-time data, ANYbotics aims to improve operational efficiency and support critical functions such as search and rescue.

EcoRobotix Ltd is a Swiss company that develops, manufactures, and sells autonomous farming machines aimed at sustainable agriculture. Founded in 2011 and based in Yverdon-les-Bains, the company specializes in a solar-powered weeding robot designed for the ecological and economical management of row crops, meadows, and intercropping cultures. This innovative machine utilizes advanced vision systems, including cameras and GPS technology, to accurately navigate crop rows and identify weeds. By applying a micro dose of herbicide directly to the detected weeds, EcoRobotix significantly reduces chemical usage and minimizes environmental impact, while also lowering costs for farmers. The company's commitment to conserving soil and hydrological resources underscores its mission to provide precise and affordable robotic solutions that enhance food production.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

Fotokite specializes in the development of autonomous aerial systems designed for real-time video and sensor data collection. Established at ETH Zurich, the company focuses on providing solutions for sectors such as news and sports broadcasting, public safety, and industrial inspection. Its drones can operate independently for over 24 hours, delivering live HD video streams that assist first responders and public safety teams in assessing and documenting incidents quickly. Since launching its first generation of products in 2016, Fotokite has partnered with notable clients including CNN, BBC, and AFP, emphasizing its commitment to making aerial sensing both accessible and secure.

Medimaps Group's mission is to design and provide medical tools to assist in the collection of quantitative information on bone microarchitecture for use in routine clinical practice. They enhance osteoporosis diagnosis by assessing the status of bone microarchitecture. They provide information to physicians to help them select the best treatment options for their patients and monitor treatment outcomes. They are working on future products to assess bone microarchitecture for application in the dental and orthopedic fields.

Developer of a cloud-based next-generation technology designed for inspecting and analyzing rotor blades. The company provides inspection tools, data analytics, and customized inspections along with an inspection platform, and offers a fully transparent view of the blade health status of the entire fleet and allows customers to capture visual blade data, process the images, and generate customizable reports, enabling windmill operators to track damage progression over time and make informed decisions about repairs.

Developer of a marketing platform designed for user and asset-level data computation and management. The company's platform combines information from all channels and recognizes behavioral patterns that allow for real-time prediction of the use of content and the display of advertisements and offers a data cleanroom type setup, enabling advertisers and media companies to securely share data in a cookieless world and achieve high reach and improved results with their digital marketing activities.

Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

Beekeeper AG is a developer of a mobile-first communication platform designed for non-desk employees, facilitating real-time communication and productivity among frontline and mobile workforces. Founded in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper serves various industries including hospitality, retail, logistics, transportation, food, manufacturing, NGOs, and event management. The platform offers tools such as messaging, content management, employee surveys, and engagement analytics, enabling managers to streamline workflows and enhance team productivity. By integrating operational systems into a central hub, Beekeeper allows users to communicate, share files, and assign tasks efficiently across different shifts and locations, thereby improving employee engagement and reducing turnover.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, it originated as a spin-off from ETH Zurich. The company's lead candidate, VS-01, is in preclinical development and aims to address acute liver disease while supporting multiple failing organs, targeting three rare indications and having received Orphan Drug Designation for acute liver failure. Versantis also has products in its pipeline, including VS-02 and VS-03, which are designed to treat chronic liver diseases and drug intoxications, respectively. These treatments aim to meet significant unmet medical needs and have the potential to enhance patient outcomes across various medical fields.

Beekeeper AG is a developer of a mobile-first communication platform designed for non-desk employees, facilitating real-time communication and productivity among frontline and mobile workforces. Founded in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper serves various industries including hospitality, retail, logistics, transportation, food, manufacturing, NGOs, and event management. The platform offers tools such as messaging, content management, employee surveys, and engagement analytics, enabling managers to streamline workflows and enhance team productivity. By integrating operational systems into a central hub, Beekeeper allows users to communicate, share files, and assign tasks efficiently across different shifts and locations, thereby improving employee engagement and reducing turnover.

SWISSto12 SA, founded in 2011 and based in Renens, Switzerland, specializes in manufacturing and supplying radio frequency (RF) and microwave components and systems. The company offers a variety of antenna products, including horn antennas, airborne antenna arrays, and custom-designed antennas tailored to specific needs. Additionally, SWISSto12 produces waveguide products, filters, and subsystems, employing advanced 3D printing and surface treatment techniques to enhance its offerings. The company is also engaged in developing a WebMCK software solution for material properties extraction. Its innovative manufacturing approaches aim to increase design flexibility while reducing costs, lead times, and weight of components. SWISSto12 serves markets including satellite communications, airborne satellites, and research institutions, with additional offices in Santa Clara, California, and Rehovot, Israel. The firm's name reflects its Swiss engineering heritage and expertise in terahertz signal technology.